Drug
Hydrocortisone butyrate clinical trials
Also written Locoid.
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2006
How studies write it
Studies that test it under each name
Brand
Studies by the year they started
3 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2016 | 1 |
| 2017 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 1
- Phase 4
- 2
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 1 · Other 2
Wake Forest University (1) · LEO Pharma (1) · Peking Union Medical College Hospital (1)
Often tested with
Tested in the same studies.
LEO 90100 (1) · Betamethasone dipropionate (1) · Betamethasone (1) · Mometasone Furoate (1)
Studies
Open first, then newest update. How each study uses hydrocortisone butyrate is read from its arms, and is right about nine times in ten.
Testing it · 3
- Medical and Surgical Treatment for Idiopathic Granulomatous MastitisStatus unknownPhase 4Peking Union Medical College HospitalNCT02959580Written as Hydrocortisone Butyrate
- Adherence to Topical Hydrocortisone 17-butyrate 0.1% (Locoid®) Using Different Vehicles in Adults With Atopic DermatitisCompletedPhase 4Wake Forest UniversityNCT00693693Written as hydrocortisone 17-butyrate 0.1% Cream preparation
- Vasoconstriction Trial With LEO 90100 Aerosol FoamCompletedPhase 1LEO PharmaNCT02973776Written as Locoid
Given in every arm · 2 — hydrocortisone butyrate is usual care beside what is tested
- Local Steroid Treatment for Idiopathic Granulomatous Mastitis (LSTIGM)Status unknownPhase 4Peking Union Medical College HospitalNCT03766997Written as Hydrocortisone Butyrate 0.1% Cream
- Efficacy and Steroid Sparing Potential Study of DGLA Cream in Early Childhood Patients With Moderate to Severe Atopic DermatitisCompletedPhase 2DS BiopharmaNCT03676933Written as Hydrocortisone Butyrate 0.1% Cream
As the comparator · 2 — what is tested is compared with hydrocortisone butyrate
- Evaluation of the Vasoconstriction Properties of MC2-01 CreamCompletedPhase 1MC2 TherapeuticsNCT03758365Written as Hydrocortisone Butyrate 0.1% Cream
- Equivalence of the Response to Vaccination of Tacrolimus Ointment to a Steroid Ointment Regimen in Children With Atopic DermatitisCompletedPhase 2Astellas Pharma IncNCT00801957Written as hydrocortisone butyrate ointment 0.1%
Codes
What other systems call hydrocortisone butyrate · ClinicalTrials.gg INT002412
- MeSH (NLM) C007975hydrocortisone-17-butyrateConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 05RMF7YPWNHYDROCORTISONE BUTYRATEConfirmed FDA, NLM, Wikidata
- RxNorm 103468One source FDA
- Wikidata Q5954738hydrocortisone butyrateConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C48022Hydrocortisone ButyrateOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C007975 | hydrocortisone-17-butyrate | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 05RMF7YPWN | HYDROCORTISONE BUTYRATE | Confirmed FDA, NLM, Wikidata |
| RxNorm | 103468 | — | One source FDA |
| Wikidata | Q5954738 | hydrocortisone butyrate | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C48022 | Hydrocortisone Butyrate | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.